Chitneni, Pooja
Kriel, Yolandie
Mathenjwa, Mxolisi
Beesham, Ivana
Qiya, Bongeka
Smith, Patricia M.
Bosman, Shannon
Jaggernath, Manjeetha
Smit, Jennifer A.
Matthews, Lynn T.
Funding for this research was provided by:
National Institute of Mental Health (K23MH12677101A1, R01MH108412)
Article History
Received: 16 October 2023
Accepted: 30 January 2025
First Online: 11 February 2025
Declarations
:
: Study procedures were approved by the University of the Witwatersrand Human Research Ethics Committee, the University of Alabama at Birmingham Institutional Review Board, and the Massachusetts General Brigham (Massachusetts General Hospital and Brigham and Women’s Hospital) Institutional Review Board. The ZINK Study protocol is registered at ClinicalTrial.gov (NCT02194308) and at the South African Health Products Regulatory Agency (SAHPRA). All participants provided written, voluntary informed consent.
: Not applicable.
: The authors declare no competing interests.